S. Lêdo

Mid- and long-term anxiety levels associated with presymptomatic testing of Huntington’s disease, Machado-Joseph disease, and familial amyloid polyneuropathy

M. Dinis, J. Sequeiros, Â. Leite, 2016, Revista brasileira de psiquiatria.

Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases.

M. Dinis, J. Sequeiros, Â. Leite, 2018, European journal of medical genetics.

Psychological aspects of pre‐symptomatic testing for Machado–Joseph disease and familial amyloid polyneuropathy type I

J. Sequeiros, M. Paneque, Â. Leite, 2006, Clinical genetics.

Pre‐symptomatic testing for neurodegenerative disorders: Middle‐ to long‐term psychopathological impact

M. Dinis, J. Sequeiros, Â. Leite, 2017, Psicothema.

Depression as the middle-and long-term impact for pre-symptomatic testing of late-onset neurodegenerative disorders

M. Dinis, J. Sequeiros, Â. Leite, 2016 .

Depression levels in Pre-symptomatic Testing for Neurodegenerative Diseases: a psychological point of view

J. Sequeiros, Â. Leite, S. Lêdo, 2014 .

Prenatal diagnosis of Machado–Joseph disease by direct mutation analysis

G. Rouleau, A. Fortuna, P. Maciel, 1998, Prenatal diagnosis.

Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.

C. Lemos, J. Sequeiros, Á. Mendes, 2019, Acta medica portuguesa.